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A b s t r a c t
Background: Echocardiography has emerged as the test of choice for the evaluation of cardiac diseases. 
Aim: To assess the prevalence of a spectrum of cardiac abnormalities detected by echocardiography in a representative sample 
of an urban adult population.
Methods: Transthoracic echocardiography was performed in a random sample of 511 men (47%) and women (53%) aged 
48–76 years selected from population registers in Krakow. Body surface area (BSA) was used to adjust echocardiographic 
parameters for variations in body size. Disease history and cardiovascular risk factors were assessed in all patients.
Results: Men smoked more frequently than women and had higher blood pressure and triglycerides and lower high density 
lipoprotein cholesterol. The most common finding was increased left ventricular (LV) end-diastolic diameter (EDd) (37%), fol-
lowed by mitral (32%), aortic (24%), or tricuspid (17%) regurgitations, LV posterior wall (24.1%) and interventricular septum 
(17.5%) thickening, increased indexed LVEDd (23%), increased left atrial diameter (LAd; 15.7%), reduced LV ejection frac-
tion (LVEF; 15.3%), segmental wall motion abnormalities (13.9%), increased indexed LAd (8.8%), dilation of the ascending 
aorta (8%), enlargement of the right ventricle (RV) (2%) and elevation of RV systolic pressure (0.6%). When adjusted for main 
cardiovascular risk factors and the presence of coronary artery disease, male sex was associated with a higher prevalence of 
enlargement of LV (LVEDd/BSA): OR = 1.8 (1.1–2.9), dilation of ascending aorta (aortic diameter/BSA): OR = 2.7 (1.3–5.8), 
and LA (LA/BSA) = OR 2.7 (1.3–5.6), as well as a decrease of LVEF: OR = 3.6 (1.9–6.5).
Conclusions: Approximately a quarter of urban adults aged 48 to 76 can be expected to have some abnormalities on echocar-
diographic examination. Some of these abnormalities such as aortic dilation, LA enlargement, LV enlargement and decreased 
LVEF are more frequently found in males than in females, even after adjustment for BSA, main cardiovascular disease risk 
factors, and the presence of coronary artery disease. The use of raw instead of indexed LAd and LVEDd overestimates the 
prevalence of LA and LV enlargement. 
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INTRODUCTION
Echocardiography has emerged as the test of choice for the 
evaluation of cardiac diseases [1]. It provides a comprehensive 
assessment of cardiac chambers and great vessels dimensions, 
left (LV) and right (RV) ventricular function, pericardial disease, 
and valvular heart disease. Abnormalities found on echo-
cardiographic study, even in patients without overt cardiac 
disease, are poor prognostic factors and prompt therapeutic 
implications [2].
Previous studies on the prevalence of cardiac abnor-
malities in the community concentrated usually on specific 
populations [3, 4] such as elderly subjects or focused on 
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only single cardiac abnormalities such as LV dysfunction or 
hypertrophy [2, 5]. Yet the prevalence of diverse echocar-
diographic abnormalities in the general adult population 
remains poorly known.
Therefore, in this cross-sectional study using echocar-
diography we aimed to assess the prevalence of a spectrum 




Data was collected from a sub-sample of participants of the 
Polish part of the Health, Alcohol and Psychosocial factors 
In Eastern Europe (HAPIEE) study. The original sample at 
baseline included men and women aged 45 to 69 randomly 
selected from an urban population registry in Krakow which 
has been described in detail previously [6, 7]. In short, be-
tween 2 December 2008 and 28 May 2009, we telephoned 
1,959 randomly selected participants of the HAPIEE study to 
invite them to the out-patient clinic for additional tests and 
interviews. A maximum of three calls were made to every 
participant. In cases of no response, a letter of invitation 
was sent. Contact was made with 1,555 (79%) persons and 
942 came to the clinic and were interviewed, so the response 
rate was 48%. To characterise the study group, every patient 
was asked about: age, history of coronary artery disease (CAD) 
and acute myocardial infarction (AMI), and the presence of 
other main cardiovascular disease (CVD) risk factors such 
as: smoking, diabetes, hypertension, hypercholesterolae-
mia, and drugs used. Additionally, in every patient, a fasting 
lipid profile consisting of total cholesterol (TC), low density 
lipoprotein cholesterol (LDL-C), high density lipoprotein cho-
lesterol (HDL-C), and triglycerides and blood pressure were 
assessed as recommended [8, 9]. Height and weight were 
measured to calculate body mass index (BMI) as follows: 
BMI = weight [kg]/height [m]2 and body surface area (BSA) 
as follows: BSA = [height (cm) × weight (kg)]/3,600)½ [10]. 
Obesity was defined as BMI ≥ 30 kg/m2 [11]. Smoking status 
was defined as a current smoker (smoked at least once dur-
ing the past month) or a non-current smoker. Transthoracic 
echocardio graphy (TTE) was performed in the first 523 con-
secutive participants of the study. This study complied with 
the Declaration of Helsinki, the institutional ethics commit-
tee approved the study protocol, and informed consent was 
obtained from each participant.
Echocardiography
A Vivid i (GE Healthcare) ultrasound machine, equipped with 
2.5–5.0 MHz probe was used for the echocardiographic evalu-
ation. Optimal standard views were obtained in patients in 
the steep left-lateral decubitus position with the patient’s left 
arm raised. Every measurement was taken three times and 
averaged. Echo examinations were made and then analysed 
by three experienced echocardiographers. The following 
parameters were measured for the purpose of the study: left 
ventricular end-diastolic diameter (LVEDd), left ventricular 
end-systolic diameter (LVESd), left ventricular ejection frac-
tion (LVEF), interventricular septal end-systolic (IVSESd) and 
end-diastolic (IVSEDd) diameter, left ventricular posterior wall 
diameter (LVPWd) at end-diastole (LVPWEDd) and end-systole 
(LVPWESd), left atrial diameter (LAd), aortic diameter (AOd), 
right ventricular diameter (RVd), mitral valve systolic (MVs) 
and mean (MVm) gradient and aortic valve (AoVs) systolic 
and mean (AoVm) gradient. Colour flow imaging was used 
to assess the presence of mitral (MR), tricuspid (TR), and 
aortic (AR) regurgitation. End-diastole and end-systole were 
defined as the frame in the cardiac cycle in which the cardiac 
dimension was the largest and the smallest, respectively [1]. 
According to the guidelines, dimensions of the LV, LA, and 
AO were additionally indexed for BSA [1]. 
LVEDd and LVESd, IVSd, and LVPWd were measured 
from the parasternal long axis view using 2D-targeted M-mode 
echocardiography at the level of the mitral valve leaflet 
tips. LVEF was calculated using the biplane method of discs 
(modified Simpson’s rule). Regional wall motion abnormalities 
were diagnosed when hypokinesis, akinesis or dyskinesis of 
LV free wall or IVS was detected. LAd was measured using 
M-mode obtained from the parasternal long axis view from the 
trailing edge of the posterior aortic wall to the leading edge of 
the posterior LA wall at the ventricular end-systole when the 
LA chamber is at its greatest dimension. AOd was measured 
at the level of sinotubular junction in 2D parasternal long 
axis view using the leading edge to leading edge technique. 
Right ventricle was measured at the proximal portion 
of the RV outflow tract from the parasternal window at 
end-diastole using the long axis view.
Aortic valve stenosis was defined as systolic aortic gra-
dient ≥ 25 mm Hg and mitral valve stenosis as mean mitral 
gradient ≥ 5 mm Hg. Dilation of ascending aorta was defined 
as AOd ≥ 36 mm or ≥ 21 mm/m2. Enlargement of the RV was 
defined as RV diastolic diameter (RVDd) ≥ 33 mm.
Doppler signal of tricuspid regurgitant wave velocity (v) 
was used to estimate RV systolic pressure (RVSP) which was 
calculated as 4 × v2 + estimated right atrial pressure and 
expressed in mm Hg. Right atrial pressure was estimated 
based on the measurement of the diameter of vena cava 
inferior and its changes during inspiration according to the 
guidelines [12].
To assess the prevalence of cardiac abnormalities, param-
eters such as LVEF, LVEDd, IVSEDd, LVPWEDd, and LAd, we 
classified into the four categories: normal, mildly abnormal, 
moderately abnormal, and severely abnormal in accordance 
with the European Society of Cardiology guidelines (Table 1) 
[1]. Other parameters were classified as normal or abnormal 
(outside the reference range) without further qualifying the 
degree of abnormality. As previously described [13], mitral 
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and tricuspid valvular regurgitation was diagnosed when more 
than trace regurgitation (within 1 cm of valve) was found, and 
aortic regurgitation was diagnosed in the presence of any 
regurgitant jet. No further quantifying of the degree of valves 
insufficiencies was made. 
Statistical analysis
Statistical analysis was performed with Statistica PL software 
[StatSoft, Inc. (2010). STATISTICA (data analysis software 
system), version 9.1, Tulsa, OK, USA www.statsoft.com] and 
MedCalc version 11.6.1.0 (MedCalc Software, Mariakerke, 
Belgium). Continuous variables were reported using median 
and interquartile range (IQR), categorical variables were de-
scribed as counts and percentages. Continuous variables were 
compared using the Mann Whitney U-test. The c2-test was 
used to compare categorical variables. Using logistic regres-
sion analysis, we adjusted the association between sex and 
cardiac abnormalities for age (< median value = 0, ≥ median 
value = 1), and the presence of hypertension, hypercholes-
terolaemia, obesity, CAD, diabetes, and current smoking. 
All tests were two-sided and the significance level was set 
at p < 0.05. 
RESULTS
Group characteristics
We enrolled in this study 523 participants who were between 
48 and 76 years of age, but further analyses were made in 
511 (98%) in whom good quality images were obtained. The 
clinical characteristics of the study population with the preva-
lence of main CVD risk factors are summarised in Table 2. Men 
(n = 238) accounted for 47% of the total population. As 
compared to women, they had higher blood pressure and 
triglycerides, and lower HDL-C. Smoking was more frequently 
declared by males than females. Age and distribution of other 
main CVD risk factors as well as cardiovascular therapies were 
similar in men and in women. 
Echocardiographic parameters
Echocardiographic parameters in men and in women of 
the study population are shown in Table 3. Men had larger 
indexed LVEDd, LVESd, LAd, AOd, and RVd than women as 
they had thicker IVS and LVPW and lower gradient through 
the mitral valve. 
Prevalence of cardiac abnormalities
The prevalence of LA and LV enlargement, IVS and LVPW 
thickening, and decrease of LVEF are shown in Table 4. Seg-
mental wall motion abnormalities of LV myocardium were 
found in 71 (13.9%) patients. Dilation of ascending aorta 
when defined as AOd ≥ 36 mm was found in 42 (8%) pa-
tients and when defined as AOd ≥ 21 mm/m2 in 32 (6%) 
study subjects. RV was enlarged in 10 (2%) patients. MR, AR 
and TR were found in 164 (32%), 124 (24%) and 85 (17%) 
participants, respectively. MVm gradient ≥ 5 mm Hg was 
found in 4 (0.8%) subjects and AoVs gradient ≥ 25 mm Hg 
was found in 2 (0.4%) patients. In most patients, the TR was 
small and therefore a good quality Doppler signal of the 
TR (as defined by well defined borders and dense spectral 
profile) was attained only in 33 patients. In all these patients, 
inferior vena cava diameter was less than 21 mm. There-
fore, right atrial pressure was assumed to be 5 mm Hg. An 
elevated RVSP ≥ 36 mm Hg was found in only three (0.6%) 
patients. The first patient was a 68-year-old man after MI, with 
LVEDd of 67 mm, LAd of 56 mm and RVd of 32 mm. The 
second patient was a 75-year-old male with reduced LVEF of 
40%, a history of CAD, LVEDd of 67 mm, LAd of 55 mm and 
RVd of 34 mm. The third patient was a 65-year-old male with 
hypertension and normal LVEF, and significant thickening of 
IVSDd of 13 mm and LVPWDd of 12 mm and LAd of 49 mm. 
Echocardiographic findings in men and women
As shown in Table 4, men more frequently than women had 
enlarged LV and LA, decreased LVEF, and thickened  IVS. 








Mildly Moderately Severely Mildly Moderately Severely
LVEDd [mm] 39–53 54–57 58–61 ≥ 62 42–59 60–63 64–68 ≥ 69
LVEDd/BSA [mm/m2] 24–32 33–34 35–37 ≥ 38 22–31 32–34 35–36 ≥ 37
LAd [mm] 27–38 39–42 43–46 ≥ 47 30–40 41–46 47–52 ≥ 52
LAd/BSA [mm/m2] 15–23 24–26 27–29 ≥ 30 15–23 24–26 27–29 ≥ 30
LVEF [%] ≥ 55 45–54 30–44 < 30 ≥ 55 45–54 30–44 < 30
IVSEDd [mm] 0.6–0.9 1.0–1.2 1.3–1.5 ≥ 1.6 0.6–1.0 1.1–1.3 1.4–1.6 ≥ 1.7
LVPWEDd [mm] 0.6–0.9 1.0–1.2 1.3–1.5 ≥ 1.6 0.6–1.0 1.1–1.3 1.4–1.6 ≥ 1.7
BSA — body surface area; IVSEDd — interventricular septum end-diastolic diameter; LAd — left atrial diameter; LVEDd — left ventricular end- 
-diastolic diameter; LVEF — left ventricular ejection fraction; LVPWEDd — left ventricular posterior wall end-diastolic diameter
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Additionally, dilation of ascending AO was more frequent 
in men than in women: 32 (13%) vs. 10 (3.7%), respec-
tively, p < 0.001 when defined as AOd ≥ 36 mm, and 
22 (9%) vs. 10 (4%), respectively, p = 0.01 when defined 
as AOd ≥ 21 mm/m2. RV was enlarged in a similar propor-
tion of men (eight; 3.4%) and women (two; 0.7%) women, 
p = 0.07. 
MR, AR and TR were found in a similar proportion of 
women and men: 92 (34%) vs. 72 (30%), p = 0.4; 61 (22%) 
vs. 63 (26%), p = 0.3; and 45 (16%) vs. 40 (17%), p = 0.8, 
respectively. 
When adjusted for main cardiovascular risk factors, male 
sex was associated with a higher prevalence of the following 
echocardiographic abnormalities: decrease of LVEF < 55% 
(OR = 3.6; CI 1.9–6.5; p < 0.001), increase of LAd/BSA 
(OR = 2.7; CI 1.3–5.6; p < 0.001), increase of LVEDd/BSA 
(OR = 1.8; CI 1.1–2.9; p < 0.001), and increase of AOd/BSA 
(OR 2.7; CI 1.3–5.8; p < 0.001).
DISCUSSION
In this cross-sectional analysis of a sample of urban adults aged 
48 to 76 years, we have presented the prevalence of major 
cardiac abnormalities detected by TTE. 
The most common finding was increased LVEDd (37%), 
followed by MR (32%), AR (24%), or TR (17%), LV posterior 
wall (24.1%) and IVS (17.5%) thickening, increased indexed 
LVEDd (23%), increased LAd (15.7%), reduced LVEF (15.3%), 
segmental wall motion abnormalities (13.9%), increased 
indexed LAd (8.8%), dilation of the ascending aorta (8%), 
enlargement of RV (2%) and elevation of RVSP (0.6%). We 
have also shown that male sex was associated with a higher 
prevalence of LV, AO and LA enlargement, and with decreased 
LVEF, irrespective of other cardiovascular risk factors and the 
presence of CAD. 
Although our study is based on a randomly selected urban 
population, we did not aim to conclude on the reference 
values of echocardiographic parameters. This resulted from 
Table 2. Group characteristics
Variable All Men (n = 238) Women (n = 273) P
Age [years] 63.0 (57.0–69.0) 64.0 (57.0–69.0) 63.0 (57.0–69.0) 0.48
BSA [m2] 1.8 (1.7–2.0) 1.8 (1.7–2.0) 1.7 (1.7–1.9) 0.98
SBP [mm Hg] 136.0 (123.5–149.5) 138.3 (128.0–151.3) 131.5 (118.5–148.0) < 0.001
DBP [mm Hg] 86.0 (78.0–93.5) 88.5 (80.0–94.5) 83.3 (77.0–92.5) < 0.001
TC [mmol/l] 5.7 (5.1–6.5) 5.7 (5.0–6.4) 5.7 (5.1–6.6) 0.09
LDL-C [mmol/L] 3.5 (2.9–4.2) 3.6 (2.9–4.1) 3.5 (3.0–4.3) 0.86
HDL-C [mmol/L] 1.4 (1.2–1.7) 1.3 (1.1–1.5) 1.5 (1.3–1.8) < 0.001
Triglycerides [mmol/L] 1.4 (1.0–1.9) 1.5 (1.1–2.1) 1.3 (1.0–1.8) 0.001
BMI [kg/m2] 27.9 (24.9–30.9) 28.1 (25.6–30.6) 27.7 (24.6–31.2) 0.61
Hypertension 273 (53) 127 (53) 146 (53) 0.95
Diabetes mellitus 92 (18) 50 (21) 42 (15) 0.12
Obesity 127 (25) 57 (24) 70 (26) 0.73
Hypercholesterolaemia 241 (47) 105 (44) 136 (50) 0.23
Smoking 102 (20) 60 (25) 42 (15) 0.006
CAD 132 (26) 55 (23) 77 (28) 0.23
History of MI 40 (8) 24 (10) 16 (6) 0.11
Beta-blocker 156 (30.5) 71 (30) 85 (31) 0.82
ACEI 147 (29) 73 (31) 74 (27) 0.96
Calcium channel blocker 71 (14) 33 (14) 38 (14) 0.91
ARB 37 (7) 15 (6) 22 (8) 0.60
Diuretics 96 (19) 46 (19) 50 (18) 0.86
Statins 112 (22 54 (23) 58 (21) 0.77
Fibrates 8 (1.6) 3 (1.3) 5 (1.8) 0.87
ASA 109 (21) 55 (23) 54 (20) 0.42
Data is expressed as median (interquartile range)/n (%); ACEI — angiotensin converting enzyme inhibitor; ARB — angiotensin receptor blocker; 
ASA — acetylsalicylic acid; BMI — body mass index; BSA — body surface area; CAD — coronary artery disease; DBP — diastolic blood pressure; 
HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol; MI — myocardial infarction; SBP — systolic blood 
pressure; TC — total cholesterol 
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a high prevalence of CVD risk factors in the studied popula-
tion. To describe the prevalence of a spectrum of cardiac 
abnormalities, we used reference values obtained from studies 
in so-called ‘normal’ subjects currently recommended by the 
European Society of Cardiology [1].
Enlargement of the LV was the most common cardiac 
abnormality detected in our study. We have also found that 
the mean LVEDd in the current study was higher than those 
reported in a previous community-based echocardiographic 
study [14] conducted in Denmark (mean LVEDd 48.4 mm 
in men and 44.2 mm in women). The latter study included 
764 representatives of the general population with a similar 
age distribution (50–89 years) to our cohort, but with signifi-
cantly lower prevalence of CVD risk factors such as hyper-
tension or diabetes. We assume that different distribution of 
CVD risk factors may, at least partly, explain the observed 
differences in the LV diameter.
Similarly to previous works, we found that valvular re-
gurgitation is highly prevalent in the adult population. In the 
Framingham Heart Study, colour Doppler echocardiography 
[13] was performed in 1,696 men and 1,893 women aged 
54 ± 10 years. After excluding trace regurgitations, MR was 
diagnosed in 19% and TR in 17% of participants, while any 
Table 3. Echocardiographic data in the studied population
Variable All Men Women P
LVEF [%] 62.0 (55.0–68.0) 60.0 (55.0–69.0) 63.0 (58.0–66.0) 0.12
LVEDd [mm] 49.6 (43.0–57.0) 53.0 (46.0–59.0) 48.0 (41.0–55.0) –*
LVEDd/BSA [mm/m2] 27.5 (23.0–31.7) 28.6 (24.8–32.8) 25.4 (22.3–30.3) < 0.001
LVESd [mm] 33.4 (27.0–39.7) 35.0 (21.0–55.0) 32.0 (26.0–39.0) –
LVESd/BSA [mm/m2] 18.0 (14.7–21.6) 19.2 (15.9–22.3) 17.0 (13.9–20.7) < 0.001
IVSEDd [mm] 9.0 (8.0–10.4) 9.4 (8.2–10.7) 9.0 (7.5–10.0) < 0.001
IVSESd [mm] 14.0 (13.0–16.2) 15.0 (13.0–17.0) 14.0 (12.1–16.0) 0.002
LVPWEDd [mm] 9.5 (8.2–10.9) 10.0 (9.0–11.0) 9.2 (8.0–10.4) 0.003
LVPWESd [mm] 14.3 (12.6–16.4) 14.5 (12.7–17.0) 14.0 (12.0–16.0) 0.02
LAd [mm] 34.5 (31.0–38.0) 36.3 (32.3–39.3) 33.5 (30.2–37.0) –
LAd/BSA [mm/m2] 18.6 (16.5–21.2) 19.3 (17.4–22.0) 18.0 (15.8–20.4) < 0.001
AOd [mm] 31.0 (28.0–33.0) 32.0 (30.0–35.0) 29.0 (27.0–32.0) –
AOd/BSA [mm/m2] 16.7 (14.7–18.6) 17.4 (15.7–19.0) 16.0 (13.7–17.8) < 0.001
RVd [mm] 24.2 (22.0–27.0) 25.7 (23.0–28.0) 23.8 (21.5–26.0) –
RVd/BSA [mm/m2] 13.2 (11.5–14.8) 13.8 (12.1–15.4) 12.7 (11.1–14.1) < 0.001
AoVs [mm Hg] 4.9 (3.7–6.3) 4.9 (3.6–5.9) 4.9 (3.7–6.6) 0.22
AoVm [mm Hg] 2.4 (1.8–3.1) 2.3 (1.8–3.0) 2.4 (1.8–3.1) 0.43
MVs [mm Hg] 3.0 (2.4–3.9) 2.9 (2.2–3.9) 3.5 (2.5–3.9) 0.04
MVm [mm Hg] 1.2 (0.9–1.6) 1.2 (0.9–1.5) 1.3 (1.0–1.6) 0.03
Data is expressed as median (interquartile range), *only indexed diameters of LV, LA and RV were compared; AOd — aortic diameter; AoVm — 
mean gradient through the aortic valve; AoVs — systolic gradient through the aortic valve; BSA — body surface area; IVSEDd — interventricular 
septum end-diastolic diameter; IVSESd — interventricular septum end-systolic diameter; LAd — left atrial diameter; LVEDd — left ventricular end-
-diastolic diameter; LVEF — left ventricular ejection fraction; LVESd — left ventricular end-systolic diameter; LVPWEDd — left ventricular posterior 
wall end-diastolic diameter; LVPWESd — left ventricular posterior wall end-systolic diameter; MVm — mean gradient through the mitral valve; 
MVs — systolic gradient through the mitral valve; RVd — right ventricular diameter
AR (including trace regurgitation) was found in 10.5% of par-
ticipants. Furthermore, is was shown that the main predictors 
of MR were age, hypertension and increased BMI, that the 
main predictors of TR were age, increased BMI and female 
gender, and that the main predictors of AR were age and male 
gender. We speculate that the characteristics of our popula-
tion, namely older age, higher prevalence of hypertension 
and increased BMI, could explain the higher proportions of 
patients with valvular regurgitations in our population than 
in the population from the Framingham study.
An important element of our study is an estimation of the 
prevalence of elevated RVSP in a sample of the general adult 
population. According to the guidelines, RVSP > 36 mm Hg 
makes a diagnosis of pulmonary hypertension (PH) possible 
[15]. Based on this recommendation, we could suspect PH 
in 0.6% of our population. The characteristics of patients 
who had the increased RVSP suggested LV systolic and/or 
diastolic dysfunction as a main cause for this abnormality. 
Current knowledge on the prevalence of PH is mostly based 
on registries from reference PH centres which may underes-
timate the true prevalence of the disease in the community 
[16]. Accordingly, some groups have aimed to assess its true 
prevalence in the general population. An Australian group 
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published recently the results of their retrospective analysis 
of a large echo database from a cohort of Armadale patients 
referred for echocardiographic examination to a central echo 
laboratory. They found PH (defined as RVSP > 40 mm Hg) in 
9.1% of the referred patients, which corresponded to 0.3% of 
the general Armadale population [17]. A potential advantage 
of our study was the collection of echocardiographic data di-
rectly from a general adult population instead of extrapolation 
of data obtained from patients referred to echocardiographic 
examination for different reasons to the general population. 
The well known limitation of any echocardiographic study in 
the field of PH is that echocardiography can only be used to 
suspect, but not to diagnose, PH which in turn requires right 
heart catheterisation. Nevertheless, currently echocardiogra-
phy is an established screening method in PH [15]. 
Cardiac geometry varies with body size. So, to adjust 
for this variation, echocardiographic variables have been 
standard ised for anthropometric measures such as BSA [18]. 
Unfortunately, there is no consensus on the optimal adjust-
ment [1]. Our data shows that this issue is clinically relevant 
since the use of raw instead of indexed LAd and LVEDd 
overestimated the prevalence of LA and LV enlargement.
Limitations of the study
The interpretation of the results of our study has some limi-
tations. First, the studied group was selected from an urban 
population which has better access to medical services  than 
the average in Poland. Second, despite putting a lot of effort 
into achieving a high participation rate, it was not high in the 
present study but similar to many other recent studies [19]. 
Earlier observations showed that participants in the HAPPIE 
study had lower total mortality than subjects who did not 
respond to invitation. Therefore, the study was done on 
a healthier part of the population [20]. This leaves a space for 
a selection bias, but the magnitude of it cannot be estimated 
because no population data based on echocardiographic 
findings has been published in Poland. Third, the popula-
tion does not represent all adults but only urban residents 
in a defined range of age. Fourth, we did not report on all 
parameters which can be obtained from TTE, but only those 
readily obtained in most echo laboratories. Additionally, due 
to the screening nature of the study, we did not aim to quantify 
the severity of valve insufficiencies.
Our study has several strengths. First, we present previous-
ly unaddressed epidemiological data on a spectrum of cardiac 
abnormalities detected by echocardiography in a community. 
Second, we have shown the prevalence of elevated RVSP 
based on echocardiographic studies obtained in a randomly 
selected adult population. Third, evidence from our study 
may have great practical use since people of middle age and 
older who were included in our study account for the most 
frequently referred group for echocardiographic examination.
Table 4. Prevalence of cardiac abnormalities 
Variable Study subjects Normal value Abnormal value P*
Mildly Moderately Severely
LVEF All 433 (84.7%) 65 9 4 
Males 187 (78.5%) 42 7 2 < 0.001
Females 246 (90.1%) 23 2 2
LA All 431 (84.3%) 64 10 6 
LA/BSA All 461 (90.2%) 38 10 2 
Males 202 (84.9%) 25 9 2 0.04
Females 259 (94.8%) 13 1 0
LVEDd All 323 (63.2%) 77 39 72 
LVEDd/BSA All 394 (77.1%) 64 13 40 
Males 171 (71.8%) 39 7 21 0.01
Females 223 (81.7%) 25 6 19
IVSEDd All 416 (82.5%) 80 9 6 
Males 183 (76.9%) 42 5 6 0.02
Females 233 (85.5%) 38 4 0
LVPWEDd All 392 (76.7%) 106 9 4 
Males 176 (33.9%) 56 5 1 0.2
Females 216 (79.1%) 50 4 3
*The p value is for the difference between the prevalence of abnormal and normal records in men and women; BSA — body surface area;  
IVSEDd — interventricular septum end-diastolic diameter; LAd — left atrial diameter; LVEDd — left ventricular end-diastolic diameter;  
LVEF — left ventricular ejection fraction; LVPWEDd — left ventricular posterior wall end-diastolic diameter
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CONCLUSIONS
Approximately a quarter of urban adults aged 48 to 76 can be 
expected to have some abnormalities on echocardiographic 
examination. Some of these abnormalities, such as aortic dila-
tion, LA enlargement, LV enlargement and decreased LVEF, 
are more frequently found in males than in females even 
after adjustment for main CVD risk factors and the presence 
of CAD. The use of raw instead of indexed LAd and LVEDd 
overestimates the prevalence of LA and LV enlargement. 
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S t r e s z c z e n i e
Wstęp: Echokardiografia jest badaniem z wyboru w diagnostyce chorób serca.
Cel: Celem niniejszej pracy była ocena częstości występowania zmian w badaniu echokardiograficznym w losowej próbie 
populacji wielkomiejskiej.
Metody: Badanie echokardiograficzne przeprowadzono w losowej próbie 511 mężczyzn (47%) i kobiet (53%) w wieku 
48–76 lat, wybranych z rejestrów ludności w Krakowie. Od wszystkich osób zebrano ujednolicony wywiad chorobowy. 
Oceniono profil czynników ryzyka i wykonano badanie echokardiograficzne przezklatkowe w sposób standardowy. Wybrane 
parametry echokardiograficzne standaryzowano na powierzchnię ciała (BSA) zgodnie z zaleceniami. 
Wyniki: Mężczyźni w porównaniu z kobietami mieli wyższe ciśnienie tętnicze, większe stężenie triglicerydów i mniejsze 
stężenie cholesterolu frakcji HDL we krwi. W badaniu echokardiograficznym najczęściej stwierdzano zwiększenie średnicy 
końcoworozkurczowej lewej komory (LV): 37%, a następnie niedomykalność zastawki mitralnej: 32%, aortalnej: 24%, trójdziel-
nej: 17%, pogrubienie ściany tylnej LV: 24,1% i przegrody międzykomorowej: 17,5%, zwiększenie zindeksowanego wymiaru 
końcoworozkurczowego LV: 23%, zwiększenie średnicy lewego przedsionka (LA): 15,7%, zmniejszenie frakcji wyrzutowej LV 
(LVEF): 15,3%, odcinkowe zaburzenia kurczliwości LV: 13,9%, zwiększenie zindeksowanej średnicy LA: 8.8%, poszerzenie 
aorty wstępującej: 8%, powiększenie prawej komory (RV): 2% i zwiększenie szacowanego ciśnienia skurczowego w RV: 
0,6%. Po wystandaryzowaniu na główne czynniki ryzyka chorób sercowo-naczyniowych i obecność choroby niedokrwiennej 
serca u mężczyzn, w porównaniu z kobietami, częściej stwierdzano: powiększenie LV (wymiar późnorozkurczowy LV/BSA): 
OR = 2,7 (1,3–5,6), poszerzenie aorty (średnica aorty/BSA): OR = 2,7 (1,3–5,8) i LA (średnica LA/BSA): OR 2,7 (1,3–5,6) 
oraz zmniejszenie LVEF: OR = 3,6 (1,9–6,5).
Wnioski: U ok. 1/4 części dorosłej populacji wielkomiejskiej w wieku 48–76 lat można się spodziewać obecności co najmniej 
1 nieprawidłowości w badaniu echokardiograficznym. Niektóre z nich, takie jak poszerzenie aorty wstępującej, powiększenie 
LA i LV oraz obniżenie LVEF występują częściej u mężczyzn niż u kobiet, nawet po uwzględnieniu wskaźnika masy ciała, 
podstawowych czynników ryzyka chorób sercowo-naczyniowych i obecności choroby niedokrwiennej serca. Wykorzystanie 
zmierzonych zamiast indeksowanych wielkości LA i LV przeszacowuje częstość występowania ich powiększenia w populacji.
Słowa kluczowe: badanie populacyjne, echokardiografia, nadciśnienie płucne, populacja ogólna 
Kardiol Pol 2014; 72, 1: 42–49
